Table 3. Comparison of levels of IL-6 (pg/ml), IL-8 (pg/ml), VEGF (pg/ml) and CRP (ng/ml) with respect to each age group.
| Age group | Group | N | IL-6 | IL-8 | VEGF | CRP |
|---|---|---|---|---|---|---|
| 50-59 |
Control |
45 |
8.55±0.37 |
13.03±0.15 |
16.96±0.57 |
4.042±0.75 |
| |
AMD |
15 |
11.18±0.80 |
12.82±0.22 |
19.38±0.63 |
1.646±0.32 |
| 60-69 |
Control |
30 |
10.10±0.39 |
12.69±1.11 |
16.82±0.69 |
4.91±0.99 |
| |
AMD |
33 |
9.73±0.45 |
13.61±0.21 |
17.35±3.87 |
4.34±0.82 |
| 70-79 |
Control |
21 |
9.117±0.48 |
12.38±0.22 |
19.18±0.56 |
1.947±0.77 |
| |
AMD |
29 |
10.54±0.43 |
13.31±0.18 |
19.14±0.51 |
3.62±0.61 |
| 80-89 |
Control |
4 |
9.866±1.24 |
12.65±0.57 |
18.07±1.90 |
4.25±2.75 |
| |
AMD |
10 |
9.51±0.89 |
13.50±0.26 |
17.45±1.22 |
4.79±1.27 |
| 90-99 |
Control |
0 |
none |
none |
none |
none |
| |
AMD |
2 |
17.72±5.35 |
14.62±1.60 |
16.24±3.87 |
-0.15±0.34 |
| ≥100 |
Control |
0 |
none |
none |
none |
none |
| AMD | 1 | 12.346 | 12.37 | 22.46 | 2.797 |
none: means no subject in these age groups could be found in the control group